Thanks nuts,
That's encouraging to hear that Provenge got approval with a similar hazard ratio. Phase IIb is not statistically powered for such a result, and the cohort is slightly different, but hopefully we see a similar result. This will show that the CANVAS trial is appropriately powered. That is the key to the phase IIb results.
Clinically though, i wonder how long the actual duration is. What I mean here is:
If the control group progressed after 7.7 minutes, and the treatment group after 10 minutes, that would still give a hazard ratio of 0.77...but this is clearly useless.
Do you know what the actual difference in the median progression free survival time was for Provenge??
- Forums
- ASX - By Stock
- nomura report target 32c
Thanks nuts, That's encouraging to hear that Provenge got...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
32.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $465.4M |
Open | High | Low | Value | Volume |
32.0¢ | 33.0¢ | 31.8¢ | $845.3K | 2.621M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 140318 | 31.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 14222 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 140318 | 0.315 |
11 | 236106 | 0.310 |
17 | 282515 | 0.305 |
22 | 424323 | 0.300 |
5 | 79251 | 0.295 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 14222 | 1 |
0.325 | 61530 | 3 |
0.330 | 244628 | 4 |
0.335 | 85951 | 4 |
0.340 | 120063 | 4 |
Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online